-ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?

被引：8

作者：

Ballow, M ^{[1
]}

机构：

[1] SUNY Buffalo, Womens & Childrens Hosp Buffalo, Div Clin Immunol & Allergy, Dept Pediat,Sch Med & Biomed Sci, Buffalo, NY 14260 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2005年 / 116卷 / 04期

关键词：

D O I：

10.1016/j.jaci.2005.07.020

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：738 / 743

页数：6

共 33 条

[11] Anti-interieukin-5 (mepolizumab) therapy for hypereosinophilic syndromes [J].

Garrett, JK ;

Jameson, SC ;

Thomson, B ;

Collins, MH ;

Wagoner, LE ;

Freese, DK ;

Beck, LA ;

Boyce, JA ;

Filipovich, AH ;

Villanueva, JM ;

Sutton, SA ;

Assa'ad, AH ;

Rothenberg, ME .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) :115-119

[12] Charles A. Janeway and Fred S. Rosen: The discovery of gamma globulin therapy and primary immunodeficiency diseases at Boston Children's Hospital [J].

Geha, RS .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (04) :937-940

[13] Natalizumab for active Crohn's disease. [J].

Ghosh, S ;

Goldin, E ;

Gordon, FH ;

Malchow, HA ;

Rask-Madsen, J ;

Rutgeerts, P ;

Vyhnalek, P ;

Zádorová, Z ;

Palmer, T ;

Donoghue, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :24-32

[14] Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma [J].

Kon, OM ;

Sihra, BS ;

Compton, CH ;

Leonard, TB ;

Kay, AB ;

Barnes, NC .

LANCET, 1998, 352 (9134) :1109-1113

[15] Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig [J].

Kremer, JM ;

Westhovens, R ;

Leon, M ;

Di Giorgio, E ;

Alten, R ;

Steinfeld, S ;

Russell, A ;

Dougados, M ;

Emery, P ;

Nuamah, IF ;

Williams, GR ;

Becker, JC ;

Hagerty, DT ;

Moreland, LW .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1907-1915

[16] T-cell costimulatory molecules: Optimal targets for the treatment of allergic airway disease with monoclonal antibodies [J].

Kroczek, R ;

Hamelmann, E .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (04) :906-909

[17] Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response [J].

Leckie, MJ ;

ten Brinke, A ;

Khan, J ;

Diamant, Z ;

O'Connor, BJ ;

Walls, CM ;

Mathur, AK ;

Cowley, HC ;

Chung, KF ;

Djukanovic, R ;

Hansel, TT ;

Holgate, T ;

Sterk, PJ ;

Barnes, PJ .

LANCET, 2000, 356 (9248) :2144-2148

[18] Adverse reactions to biologic agents: Focus on autoimmune disease therapies [J].

Lee, SJ ;

Kavanaugh, A .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (04) :900-905

[19] Monoclonal antibodies and fusion proteins in medicine [J].

Liossis, SNC ;

Tsokos, GC .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (04) :721-729

[20] Anti-interleukin-12 antibody for active Crohn's disease [J].

Mannon, PJ ;

Fuss, IJ ;

Mayer, L ;

Elson, CO ;

Sandborn, WJ ;

Present, D ;

Dolin, B ;

Goodman, N ;

Groden, C ;

Hornung, RL ;

Quezado, M ;

Neurath, MF ;

Salfeld, J ;

Veldman, GM ;

Schwertschlag, U ;

Strober, W .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (20) :2069-2079

← 1 2 3 4 →